Utama › Skleroderma Difus › Tennessee
Kajian klinikal Skleroderma Difus di Tennessee
4 kajian untuk Skleroderma Difus sedang mencari peserta di lokasi di Tennessee.
Teks kajian rasmi (Bahasa Inggeris)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- West Tennessee Research Institute, Jackson
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06470048Platform Clinical Study for Conquering Scleroderma
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Hixson, Hixson
- Artiva Investigational Site Jackson, Jackson
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06991114The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- Vanderbilt University Medical Center, Nashville
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jan 2026 · NCT06675344Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.